Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
19.85
-0.48 (-2.36%)
At close: Sep 11, 2026

SHA:688739 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
42.78131.79342.82465.92714.02892.49
Depreciation & Amortization
213.18175.01172.18125.27121.22116.1
Other Amortization
7.657.653.813.712.221.32
Loss (Gain) From Sale of Assets
00-0.09-2.48-0.04-0.01
Asset Writedown & Restructuring Costs
107.8281.171.80.870.830.71
Loss (Gain) From Sale of Investments
-72.5-67.3660.0220.27-27.25-14.2
Provision & Write-off of Bad Debts
8.448.448.6612.7715.0816.44
Other Operating Activities
36.3239.633.2155.437.988.11
Change in Accounts Receivable
-21.5118.39-18.0213.82-156.41-436.49
Change in Inventory
-42.16-52.76-73.270.42-104.11-109.74
Change in Accounts Payable
1.74-2.71-27.59-11.84-17.5545.15
Change in Other Net Operating Assets
0.120.130.060.060.080.1
Operating Cash Flow
285.15340.86500.96677.01546.49506.38
Operating Cash Flow Growth
-39.62%-31.96%-26.00%23.88%7.92%-41.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-213.35-308.08-362.48-551.99-511.61-508.35
Sale of Property, Plant & Equipment
0010.980.020.150.02
Cash Acquisitions
-0.13-0.13-0.06-0.06-0.08-0.09
Investment in Securities
-97.98154.4156.81-883.23,327-2,598
Other Investing Activities
32.9326.9431.9232.9575.0440.72
Investing Cash Flow
-278.52-126.88-162.83-1,4022,890-3,066

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--6.51-5.85-6.38-5.41-5.63
Lease Payments
-6.51-6.51-5.85-6.38-5.41-5.63
Net Debt Issued (Repaid)
-6.51-6.51-5.85-6.38-5.41-5.63
Issuance of Common Stock
-----4,371
Repurchase of Common Stock
-10.79-10.79-50-99.99--
Common Dividends Paid
-41.15-329.23-329.38-416.32-416.3-
Dividends Paid
-41.15-329.23-329.38-416.32-416.3-
Other Financing Activities
-6.71-----18.95
Financing Cash Flow
-65.16-346.53-385.23-522.69-421.74,347

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.720.690.552.291.58-0.36
Net Cash Flow
-60.26-131.86-46.55-1,2463,0171,787

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
71.7932.78138.48125.0234.89-1.97
Free Cash Flow Growth
-25.44%-76.33%10.76%258.36%--
Free Cash Flow Margin
5.28%2.36%8.26%7.14%1.92%-0.09%
Free Cash Flow Per Share
0.170.080.340.300.08-0.01
Levered Free Cash Flow
-52.45-170.6852.1346.39-182.35-228.08
Unlevered Free Cash Flow
-51.56-169.7953.1147.28-181.53-227.12
Free Cash Flow After Leases
65.2926.27132.63118.6429.48-7.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
140.1494.29177.45182.09211.18198.48
Change in Working Capital
-58.54-35.44-121.46-4.75-287.57-514.57